Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pirozzi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Chest|January 21, 2020
Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS CohortRobert M Burkes, Agathe S Ceppe, Claire M Doerschuk, et al.
Respiratory Research|November 21, 2018
Heterogeneous burden of lung disease in smokers with borderline airflow obstructionCheryl S Pirozzi, Tian Gu, Pedro M Quibrera, et al.
JAMA Internal Medicine|December 10, 2019
Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in SmokersLaura M Paulin, Amanda J Gassett, Neil E Alexis, et al.
The Science of the Total Environment|March 23, 2022
Ambient ozone effects on respiratory outcomes among smokers modified by neighborhood poverty: An analysis of SPIROMICS AIRDaniel C Belz, Han Woo, Nirupama Putcha, et al.
The European Respiratory Journal|September 18, 2025
Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiencyJ Michael Wells, Ingrid L Titlestad, Hanan Tanash, et al.
Annals of the American Thoracic Society|March 11, 2025
Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS CohortIgor Barjaktarevic, Roxana Hixson, Zian Zhuang, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 3, 2022
Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS CohortBonnie E Ronish, David J Couper, Igor Z Barjaktarevic, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort AnalysisIgor Z Barjaktarevic, Russell G Buhr, Xiaoyan Wang, et al.
Annals of the American Thoracic Society|October 24, 2025
Effect of a Self Directed Lifestyle-based Weight Management Program among Patients with Comorbid COPD and Sleep Apnea: A Secondary Analysis of the INSIGHT COPD TrialAristotle G Leonhard, Scott Coggeshall, Emily Gleason, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Chest|January 21, 2020
Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS CohortRobert M Burkes, Agathe S Ceppe, Claire M Doerschuk, et al.
Respiratory Research|November 21, 2018
Heterogeneous burden of lung disease in smokers with borderline airflow obstructionCheryl S Pirozzi, Tian Gu, Pedro M Quibrera, et al.
JAMA Internal Medicine|December 10, 2019
Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in SmokersLaura M Paulin, Amanda J Gassett, Neil E Alexis, et al.
The Science of the Total Environment|March 23, 2022
Ambient ozone effects on respiratory outcomes among smokers modified by neighborhood poverty: An analysis of SPIROMICS AIRDaniel C Belz, Han Woo, Nirupama Putcha, et al.
The European Respiratory Journal|September 18, 2025
Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiencyJ Michael Wells, Ingrid L Titlestad, Hanan Tanash, et al.
Annals of the American Thoracic Society|March 11, 2025
Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS CohortIgor Barjaktarevic, Roxana Hixson, Zian Zhuang, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 3, 2022
Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS CohortBonnie E Ronish, David J Couper, Igor Z Barjaktarevic, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort AnalysisIgor Z Barjaktarevic, Russell G Buhr, Xiaoyan Wang, et al.
Annals of the American Thoracic Society|October 24, 2025
Effect of a Self Directed Lifestyle-based Weight Management Program among Patients with Comorbid COPD and Sleep Apnea: A Secondary Analysis of the INSIGHT COPD TrialAristotle G Leonhard, Scott Coggeshall, Emily Gleason, et al.
Pageof 2